Inactive

Active Pharmaceutical Ingredients (API) Manufacturer Data Acquisition US Food Drug and Administration (FDA) Center for Drug Evaluation and Research (CDER) is interested in improving and validating the... Active Pharmaceutical Ingredients (API) Manufacturer Data Acquisition US Food Drug and Administration (FDA) Center for Drug Evaluation and Research (CDER) is interested in improving and validating their understandingof the worldwide Active Pharmaceutical Ingredients (API), their manufacturing facilities and their activities, and recognizing the critical importance that API manufacturers have in producing safe and effective drugs. To that end, CDER would like to obtain worldwide API manufacturing facility and product data that can assist CDER in programs that rely on manufacturing information for the purposes of compliance, surveillance, enforcement, drug shortages and user fee collections. For full description of this requirement, please review the attached RFQ document.